CytoSorbents: Q3 Earnings Snapshot
In this article:
PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — CytoSorbents Corp. (CTSO) on Thursday reported a loss of $9.2 million in its third quarter.
The Princeton, New Jersey-based company said it had a loss of 21 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The blood purification therapy company posted revenue of $8.8 million in the period, which also missed Street forecasts. Six analysts surveyed by Zacks expected $9.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO
